Suppr超能文献

Thoracic EndoVascular Stent Graft Repair for Aortic Aneurysm.

作者信息

Kim Joung Taek, Yoon Yong Han, Lim Hyun Kyung, Yang Ki Hwan, Baek Wan Ki, Kim Kwang Ho

机构信息

Department of Thoracic and Cardiovascular Surgery, Inha University Hospital, Korea.

出版信息

Korean J Thorac Cardiovasc Surg. 2011 Apr;44(2):148-53. doi: 10.5090/kjtcs.2011.44.2.148. Epub 2011 Apr 14.

Abstract

BACKGROUND

The number of cases employing thoracic endovascular aortic repair (TEVAR) has been increasing due to lower morbidity and mortality compared to open repair technique. The aim of this study is to evaluate the outcome of TEVAR for thoracic aortic diseases.

MATERIALS AND METHODS

Sixteen patients underwent TEVAR from October 2003 to April 2010. Mean age at operation was 59 years (2078 years), and 11 were male. Indications for TEVAR were large aortic diameter (>5.5 cm) upon presentation in 6 patients, increasing aortic diameter during the follow-up period in 4, traumatic aortic rupture in 3, persistent chest pain in 2, and ruptured aortic aneurysm in one. The mean diameter, length and the number of the stents were 33 mm (2640 mm), 12 cm (9.516.0 cm), and 1.25 (12), respectively. Aortography employing Multi-detector computerized tomography (MDCT) technique was performed at one week, and patients were followed up in the out-patient department at one month, 6 months, and one year postoperatively.

RESULTS

Primary technical success showing complete exclusion of the aneurysm was achieved in 15 patients. One patient showed a small endo-leak (type 1). Four patients developed perioperative stroke: Three recovered without sequelae, and one showed mild right-side weakness. There was no operative mortality. Diameter of the thoracic aorta covered by stent graft changed within 10% range in 12 patients, decreased by more than 10% in 3, and increased by more than 10% in one during mean follow-up duration of 18 months (1~73 months). There was no recurrence-related death during this period.

CONCLUSION

Intermediate-term outcome after TEVAR was encouraging. Indications for TEVAR could be extended for other thoracic aortic diseases.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/3249291/cec3bf2d8405/kjtcs-44-148-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验